Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering cells to secrete growth factors

T Ebendal1, P Lönnerberg, G Pei

  • 1Department of Developmental Biology, Uppsala University, Sweden.

Journal of Neurology
|December 1, 1994
PubMed
Summary

Genetically engineered muscle cells producing nerve growth factor (NGF) successfully supported damaged central cholinergic neurons in rats. This neurotrophin delivery method shows promise for treating neurodegenerative diseases like Alzheimer's and Parkinson's.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term follow-up of implants placed after Le Fort I osteotomy with interpositional autogenous bone grafts: a retrospective study.

International journal of implant dentistry·2025
Same author

Formation of an outer glassy shell hinders the drying of trehalose droplets.

Cryo letters·2025
Same author

A benchmark for Monte Carlo simulations in gamma-ray spectrometry Part II: True coincidence summing correction factors.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2023
Same author

Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy.

Scientific reports·2023
Same author

Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle.

International journal of cardiology·2023
Same author

WGCNA Application to Proteomic and Metabolomic Data Analysis.

Methods in enzymology·2017

Area of Science:

  • Neuroscience
  • Cell Biology
  • Regenerative Medicine

Background:

  • Central cholinergic neurons require neurotrophins, particularly nerve growth factor (NGF), for survival and function.
  • NGF-producing cell grafts have previously shown potential in rescuing damaged cholinergic neurons.
  • Developing effective cell-based therapies for neurodegenerative diseases is a critical area of research.

Purpose of the Study:

  • To engineer skeletal muscle cells to produce high concentrations of human recombinant NGF.
  • To evaluate the therapeutic potential of these genetically modified cells in a rat model of cholinergic neuron damage.
  • To explore the application of engineered neurotrophin-producing cells for treating neurodegenerative conditions.

Main Methods:

  • Immortalized rat embryonic skeletal muscle cells were transfected with a human NGF construct.

Related Experiment Videos

  • NGF production was confirmed using a biological assay with embryonic sympathetic ganglia.
  • Clone RM22, exhibiting high NGF production, was grafted into the rat brain following fimbria-fornix lesions.

    • Main Results:

    • Clone RM22 demonstrated consistent, high-concentration production of human recombinant NGF.
    • Grafting RM22 cells into lesioned rat brains influenced basal forebrain cholinergic neurons.
    • The study provides evidence for the neuroprotective effects of NGF-delivered via engineered cells.

    Conclusions:

    • Genetically engineered NGF-producing cells can rescue damaged central cholinergic neurons.
    • This approach holds therapeutic potential for Alzheimer's and Parkinson's diseases.
    • Engineered cells offer a platform for delivering customized neurotrophins for novel therapeutic strategies.